UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000001013
Receipt No. R000001209
Scientific Title Phase I clinical study of tumor-specific vaccine using novel tumor antigen SCRN1-derived HLA*0201 restricted epitope peptide against advanced gastric cancer
Date of disclosure of the study information 2008/02/04
Last modified on 2009/05/26 10:07:41

No. Disposal Last modified on Item of update
1 Insert 2008/02/04 19:28:54
2 Update 2008/02/04 19:35:41 Acronym
3 Update 2008/02/04 19:38:26 Organization
4 Update 2009/05/26 10:07:41 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Contact us.